GlaxoSmithKline facing fresh allegations of corruption

The UK-based drugs giant GlaxoSmithKline is facing fresh allegations of corruption after Chinese police accused senior executive Mark Reilly of bribery.

In a statement by the official Xinhua News Agency, police said GSK's Mark Reilly is accused of pressing sales teams to bribe doctors, hospital officials and health institutions.

It said that resulted in "illegal revenue" of billions of yuan - hundreds of millions of dollars.